Fund Holdings — Avoro Capital Advisors LLC

Total Portfolio Value:
$6.41B
Total Bought:
$879.60M
Total Sold:
$745.86M
Net Transaction:
+$133.74M
Notable People:
Behzad Aghazadeh, Avoro Capital L.P.
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)2,760,3002,675,000-85,300$973.94M$824.62M12.87%-$149.32M
Ascendis Pharma A/SADR(ASND)5,103,0555,218,000+114,945$702.54M$813.28M12.69%+$110.74M
argenx SEADR(ARGX)1,238,4671,235,177-3,290$761.66M$731.06M11.41%-$30.60M
Madrigal Pharmaceuticals, Inc.(MDGL)2,029,0002,022,222-6,778$626.09M$669.82M10.46%+$43.73M
Krystal Biotech, Inc.(KRYS)2,628,8222,731,000+102,178$411.83M$492.40M7.69%+$80.57M
Blueprint Medicines Corp1,185,0003,850,000+2,665,000$103.36M$340.76M5.32%+$237.41M
Apellis Pharmaceuticals Inc.
COM
12,222,22212,222,2220$390.01M$267.30M4.17%-$122.71M
Avidity Biosciences Inc7,500,0007,625,000+125,000$218.10M$225.09M3.51%+$6.99M
Xenon Pharmaceuticals Inc.(XENE)5,666,6665,741,666+75,000$222.13M$192.63M3.01%-$29.50M
Soleno Therapeutics Inc2,525,0002,525,0000$113.50M$180.41M2.82%+$66.91M
Kymera Therapeutics, Inc.(KYMR)5,150,0006,460,000+1,310,000$207.18M$176.81M2.76%-$30.37M
Sarepta Therapeutics, Inc.(SRPT)2,555,5552,674,835+119,280$310.73M$170.71M2.66%-$140.02M
Amicus Therapeutics Inc.
COM
23,175,00020,500,000-2,675,000$218.31M$167.28M2.61%-$51.03M
Arrowhead Pharmaceuticals, Inc.(ARWR)11,111,11111,111,1110$208.89M$141.56M2.21%-$67.33M
Vera Therapeutics, Inc.(VERA)5,610,0005,701,900+91,900$237.25M$136.96M2.14%-$100.29M
Merus N V2,125,0003,000,000+875,000$89.36M$126.27M1.97%+$36.91M
MoonLake ImmunotherapeuticsCL A(MLTX)2,770,1002,770,1000$150.00M$108.23M1.69%-$41.77M
Intra-Cellular Therapies Inc3,050,000625,000-2,425,000$254.74M$82.45M1.29%-$172.29M
Alkermes plc(ALKS)2,450,0002,450,0000$70.46M$80.90M1.26%+$10.44M
BioCryst Pharmaceuticals, Inc.(BCRX)11,865,0008,700,000-3,165,000$89.22M$65.25M1.02%-$23.97M
Ocular Therapeutix, Inc.(OCUL)8,060,0008,060,0000$68.83M$59.08M0.92%-$9.75M
Centessa Pharmaceuticals PlcADR04,050,000+4,050,000$0$58.24M0.91%+$58.24M
89bio Inc4,100,0006,350,000+2,250,000$32.06M$46.16M0.72%+$14.10M
MannKind Corporation(MNKD)8,750,0008,750,0000$56.26M$44.01M0.69%-$12.25M
Vaxcyte, Inc.(PCVX)1,175,0001,000,000-175,000$96.19M$37.76M0.59%-$58.43M
Tourmaline Bio Inc2,222,2222,425,000+202,778$45.07M$36.88M0.58%-$8.18M
Ultragenyx Pharmaceutical Inc.(RARE)830,000830,0000$34.92M$30.05M0.47%-$4.86M
Taysha Gene Therapies, Inc.(TSHA)19,999,99919,999,9990$34.60M$27.80M0.43%-$6.80M
uniQure N.V.(QURE)2,175,0002,175,0000$38.41M$23.05M0.36%-$15.36M
Monte Rosa Therapeutics, Inc.(GLUE)4,345,0004,645,548+300,548$30.15M$21.56M0.34%-$8.60M
Autolus Therapeutics plcADR(AUTL)9,910,6429,910,6420$23.29M$15.36M0.24%-$7.93M
Septerna, Inc.(SEPN)1,110,0001,337,500+227,500$25.42M$7.74M0.12%-$17.67M
Whitehawk Therapeutics, Inc.(WHWK)2,849,4022,849,4020$8.99M$5.07M0.08%-$3.92M
BioMarin Pharmaceutical Inc.(BMRN)1,462,5000-1,462,500$96.13M$0—-$96.13M
CG Oncology, Inc.(CGON)700,0000-700,000$20.08M$0—-$20.08M
Iovance Biotherapeutics, Inc.(IOVA)3,500,0000-3,500,000$25.90M$0—-$25.90M
Kura Oncology, Inc.(KURA)2,250,0000-2,250,000$19.60M$0—-$19.60M
Olema Oncology, Inc.(OLMA)1,651,9820-1,651,982$9.63M$0—-$9.63M
Rocket Pharmaceuticals, Inc.(RCKT)1,200,0000-1,200,000$15.08M$0—-$15.08M
Syndax Pharmaceuticals, Inc.(SNDX)2,275,0000-2,275,000$30.08M$0—-$30.08M
Page 1 of 1
Avoro Capital Advisors LLC — 13F Holdings — Q1 2025 | TickerTrail